Healthequity Inc
NASDAQ:HQY
Relative Value
The Relative Value of one HQY stock under the Base Case scenario is 94.7 USD. Compared to the current market price of 78.55 USD, Healthequity Inc is Undervalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
HQY Competitors Multiples
Healthequity Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 6.8 | 121.4 | 25.7 | 56.5 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
454B USD | 1.2 | 29.6 | 13.4 | 15.1 | ||
US |
Elevance Health Inc
NYSE:ELV
|
122.5B USD | 0.7 | 19.6 | 13.1 | 15.4 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | 18.6 | 12.7 | 14.7 | ||
US |
Centene Corp
NYSE:CNC
|
40.1B USD | 0.3 | 14.7 | 8 | 10.8 | ||
US |
Humana Inc
NYSE:HUM
|
38.6B USD | 0.4 | 19.4 | 9 | 11 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20B USD | 0.6 | 18.7 | 7.5 | 8.3 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | 45.6 | 19.2 | 23.6 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
28.9B BRL | 1.1 | -39 | 10.9 | 34.2 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
3.1B USD | 2.8 | 49.3 | 41.7 | 43.2 | ||
US |
Magellan Health Inc
NASDAQ:MGLN
|
2.5B USD | 0.5 | 8.3 | 12.5 | 37.2 |